Jun 07, 2015
1:10
For every 10 shares held, investors received 1. The price per share adjusted from $75.50 to $755.00.
The split itself did not change the total investment value.
BioLineRX Ltd. (TASE:BLRX) operates in the Pharmaceuticals: major industry.
BioLineRX Ltd. company overviewBioLineRX Ltd.'s most recent stock split was on June 7, 2015. It was a 1-for-10 reverse split, so shareholders received 1 share for every 10 they held.
BioLineRX Ltd. (TASE:BLRX) has split its stock 2 times: a 528-for-421 split on June 21, 2009 and a 1-for-10 reverse split on June 7, 2015.
BioLineRX Ltd. has split its stock 2 times. This history records 2 splits between June 21, 2009 and June 7, 2015.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In BioLineRX Ltd.'s 1-for-10 reverse split on June 7, 2015, every 10 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
BioLineRX Ltd. has not announced a new split in our records. Its most recent split was on June 7, 2015, 11 years ago. Companies announce splits in advance, and any new TASE:BLRX split will appear on this page.
Already premium?